Soliris 300 MG vial
Ended Awarded
- Contract number
- VA26216F1073
- Awardee
-
Alexion Pharmaceuticals Inc. UEI DKCXLGANZAN3
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $89,993
Award facts
- Contract value 100% obligated
- $89,993.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cheshire, CT 06410, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Alexion Pharmaceuticals Inc. for the drug Soliris 300 mg vial. The contract was awarded under the GSA Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB), with a firm-fixed-price pricing type. The contract has a ceiling value of $89,993.19 and a period of performance ending on December 31, 2015. Alexion, a global biopharmaceutical company, is the prime contractor and there are no noted subcontractors. This contract facilitated the provision of Soliris to the VA to treat patients with rare diseases. The VA has also awarded Alexion a Blanket Purchase Agreement (BPA) for the drug Strensiq, with a potential value of $4,239,517.80 and a period of performance from September 1, 2022 through August 31, 2024. This BPA allows VA medical centers nationwide to purchase Strensiq to treat patients with perinatal/infantile- and juvenile-onset hypophosphatasia.
Quick answers
Who was awarded contract VA26216F1073?
VA26216F1073 was awarded to Alexion Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on November 19, 2015.
How much is contract VA26216F1073 worth?
The government has obligated $89,993 on VA26216F1073.
Is contract VA26216F1073 an order under another contract?
Yes. VA26216F1073 is a delivery order under V797D30015, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26216F1073 competed?
The extent of competition for VA26216F1073 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award